New eczema study elicits praise from Ta dermatologist


(MENAFNEditorial) Effecting roughly 31.6 million Americans eczema is a way of life for a significant portion of the population. Now thanks to a recent study out of Singapore experts have a little more insight into this widespread skin condition.

The study performed by the A*STAR Singapore Institute for Clinical Sciences found that by determining the age of the sufferer when the disease activated could help determine the cause of the condition.

It''s a development that provides welcomed news to those who deal with the disease on a daily basis.

''Understanding what can lead to eczema activation is vital in fighting the condition moving forward'' says Tampa dermatologist Dr. Seth Forman. ''Whether it focuses on prevention finding a cure or simply understanding more about the disease the community should be encouraged that more and more studies like this are coming to light.''

During the analysis the team monitored 18 months of data from more than 1000 Asian newborns. Results found correlations related to everything from maternal allergies and day care attendance to antibiotic usage in the first six months of a child''s life.

Also known as atopic dermatitis eczema is a medical skin condition characterized by inflammation and irritation of the epidermis. Common symptoms include itchiness and dryness of the skin and a development of thick red patches on areas of the body including the face hands and neck.

Furthermore the disease has the potential to significantly alter the quality of life of those suffering from the condition. Eczema effects one out of five children and roughly 5-10% of adults.

With that in mind Dr. Forman has continued to conduct clinical trials in search of successful eczema treatments. His latest trials have seen significant improvement among participants.

''I believe this could be a breakthrough treatment'' said Dr. Forman. ''We''ve seen promising results so far and we''re excited about pushing forward with the trials.''

While Dr. Forman has found success with his recent clinical trials the Tampa dermatologist continues to encourage the involvement of new patients and volunteers.

Dr. Forman is the founder of Forman Dermatology and Skin institute located in Tampa Fla. and has appeared on TV shows across the country including the nationally syndicated show ''The Doctors'' to provide sun-protection tips and to demonstrate his breakthrough skin cancer treatments.

If interested in being a part of the clinical trial for eczema or for more on Dr. Seth Forman Tampa dermatology or Forman Dermatology and Skin Cancer Institute please visit www.FormanDerm.com.

About Dr. Seth Forman: Dr. Forman is a board-certified dermatologist practicing in Tampa Florida. He was voted the ''Best Dermatologist in Carrollwood'' in 2011 and 2012 by the Carrollwood News and Tribune. In December 2011 he opened his new Tampa dermatology office Forman Dermatology and Skin Cancer Institute where he gives psoriasis sufferers access to the latest treatment options including topical and oral medications as well as biological and phototherapy. Dr. Forman is one of the few Tampa dermatologists to offer narrowband light therapy which uses pharmaceutical grade light to suppress psoriasis. He''s also one of the few board-certified dermatologists in the U.S. to use the SRT-100 radiotherapy to treat basal cell carcinoma the most common form of skin cancer.

MEDIA CONTACT
Adam Farragut
PR Firm: The Publicity Agency
Email:
Phone: (813) 708-1220 x 7778
Website: www.thepublicityagency.com

Direct link:http://www.prnewschannel.com/2016/01/18/new-eczema-study-elicits-praise-from-tampa-dermatologist/

SOURCE:Forman Dermatology and Skin Cancer Institute

This press release is distributed by PR NewsChannel. Your News. Everywhere.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Newsletter